These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22034893)

  • 21. Correlation between p38 mitogen-activated protein kinase and human telomerase reverse transcriptase in sarcomas.
    Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Sugita T; Ochi M
    J Exp Clin Cancer Res; 2012 Jan; 31(1):5. PubMed ID: 22243975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches.
    Romeo S; Bovée JV; Kroon HM; Tirabosco R; Natali C; Zanatta L; Sciot R; Mertens F; Athanasou N; Alberghini M; Szuhai K; Hogendoorn PC; Dei Tos AP
    Virchows Arch; 2012 Nov; 461(5):561-70. PubMed ID: 23001328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker.
    Hartel PH; Jackson J; Ducatman BS; Zhang P
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():24-8. PubMed ID: 16972949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant fibrous histiocytoma of bone: A survival analysis from the National Cancer Database.
    Malik AT; Baek J; Alexander JH; Voskuil RT; Khan SN; Scharschmidt TJ
    J Surg Oncol; 2020 Jun; 121(7):1097-1103. PubMed ID: 32133661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of MAPK pathway in bone and soft tissue tumors.
    Sasaki K; Hitora T; Nakamura O; Kono R; Yamamoto T
    Anticancer Res; 2011 Feb; 31(2):549-53. PubMed ID: 21378337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histiocyte-like cells expressing factor XIIIa do not belong to the neoplastic cell population in malignant fibrous histiocytoma.
    Szollosi Z; Nemeth T; Egervari K; Nemes Z
    Pathol Res Pract; 2005; 201(5):369-77. PubMed ID: 16047946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.
    Wallenius V; Hisaoka M; Helou K; Levan G; Mandahl N; Meis-Kindblom JM; Kindblom LG; Jansson JO
    Am J Pathol; 2000 Mar; 156(3):821-9. PubMed ID: 10702398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipogenic, osteogenic and myofibrogenic differentiations of a rat malignant fibrous histiocytoma (MFH)-derived cell line, and a relationship of MFH cells with embryonal mesenchymal, perivascular and bone marrow stem cells.
    Yamate J; Ogata K; Yuasa T; Kuwamura M; Takenaka S; Kumagai D; Itoh K; LaMarre J
    Eur J Cancer; 2007 Dec; 43(18):2747-56. PubMed ID: 18036812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant fibrous histiocytoma of the floor of mouth: a case report and review of the literature.
    Wu Y; Liu X; Lv Y; Li Z
    J Stomatol Oral Maxillofac Surg; 2022 Jun; 123(3):e106-e111. PubMed ID: 34224923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma.
    Orth MF; Gerke JS; Knösel T; Altendorf-Hofmann A; Musa J; Alba-Rubio R; Stein S; Hölting TLB; Cidre-Aranaz F; Romero-Pérez L; Dallmayer M; Baldauf MC; Marchetto A; Sannino G; Knott MML; Wehweck F; Ohmura S; Li J; Hakozaki M; Kirchner T; Dandekar T; Butt E; Grünewald TGP
    Int J Cancer; 2019 Feb; 144(4):859-867. PubMed ID: 30267407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Features and Outcomes of Undifferentiated Pleomorphic Sarcoma of Bone and Soft Tissue.
    Gusho CA; Lee L; Guntin J; Blank AT
    J Surg Res; 2022 Feb; 270():313-320. PubMed ID: 34731728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Undifferentiated pleomorphic sarcoma with co-existence of KRAS/PIK3CA mutations.
    Li B; Li L; Li X; Wang Y; Xie Y; Liu C; Li F
    Int J Clin Exp Pathol; 2015; 8(7):8563-7. PubMed ID: 26339434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as risk biomarkers for malignant fibrous histiocytoma.
    Xun J; Li Z; Song X; Wang X
    Mitochondrial DNA; 2015 Jun; 26(3):380-3. PubMed ID: 24083973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant fibrous histiocytoma of visceral organs: clinicopathologic features and diagnostic value of ezrin and HMG-CoA reductase.
    Gu J; Zhang S; Wu X; Shi J; Zhang B; Zhang X; Yang J; Obulkasim H; Duan F; Deng C; He J; Zou X; Ding Y
    Int J Clin Exp Pathol; 2015; 8(3):2876-87. PubMed ID: 26045796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas.
    Serrano C; Romagosa C; Hernández-Losa J; Simonetti S; Valverde C; Moliné T; Somoza R; Pérez M; Vélez R; Vergés R; Domínguez R; Carles J; Ramón Y Cajal S
    Cancer; 2016 Jan; 122(1):99-107. PubMed ID: 26479291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological characteristics and survival of malignant fibrous histiocytoma of the bone: A population-based study using the SEER database.
    Liu B; Wei H; Ren YJ; Zou D; Zhang K; Ma Q; Xiao X
    PLoS One; 2020; 15(6):e0232466. PubMed ID: 32492019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
    Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Akiyama T; Sugaya J; Nakatani F; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2022 Jan; 35(1):384-391. PubMed ID: 34665443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.
    Yang HK; Jeong KC; Kim YK; Jung ST
    Clin Orthop Surg; 2014 Dec; 6(4):443-54. PubMed ID: 25436070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.
    Ueda T; Araki N; Mano M; Myoui A; Joyama S; Ishiguro S; Yamamura H; Takahashi K; Kudawara I; Yoshikawa H
    J Clin Pathol; 2002 Nov; 55(11):853-8. PubMed ID: 12401825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
    Lewin J; Garg S; Lau BY; Dickson BC; Traub F; Gokgoz N; Griffin AM; Ferguson PC; Andrulis IL; Sim HW; Kamel-Reid S; Stockley TL; Siu LL; Wunder JS; Razak ARA
    Int J Cancer; 2018 Jan; 142(1):57-65. PubMed ID: 28891048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.